Sign Up to like & get
recommendations!
0
Published in 2018 at "Nuclear Medicine Communications"
DOI: 10.1097/mnm.0000000000000926
Abstract: Background and aims Functioning and symptomatic disease resistant to conventional therapies constitutes a subset amongst neuroendocrine tumors (NETs) that are commonly considered for peptide receptor radionuclide therapy (PRRT). The aim of this study was to…
read more here.
Keywords:
progressive symptomatic;
prrt;
neuroendocrine tumors;
receptor radionuclide ... See more keywords